id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-N-0150-0017,FDA,FDA-2022-N-0150,"Revocation of Authorization of Emergency Use of In Vitro Diagnostic Device for Detection and/or Diagnosis
of COVID–19; Availability",Notice,Announcement,2025-08-15T04:00:00Z,2025,8,2025-08-15T04:00:00Z,,2025-08-15T17:38:51Z,2025-15556,0,0,09000064b8f00dc5
FDA-2022-N-0150-0016,FDA,FDA-2022-N-0150,"Revocation of Authorization of Emergency Use of In Vitro Diagnostic Device for Detection and/or Diagnosis
of COVID–19; Availability",Notice,Announcement,2025-06-26T04:00:00Z,2025,6,2025-06-26T04:00:00Z,,2025-06-26T17:45:21Z,2025-11822,0,0,09000064b8e3225c
FDA-2022-N-0150-0015,FDA,FDA-2022-N-0150,Revocation of Four Authorizations of Emergency Use of In Vitro Diagnostic Devices for Detection and/or Diagnosis of COVID–19; Availability,Notice,Announcement,2025-05-29T00:00:00Z,2025,5,2025-05-29T00:00:00Z,,2025-05-29T17:31:38Z,2025-09678,0,0,09000064b8dc7841
FDA-2022-N-0150-0014,FDA,FDA-2022-N-0150,Revocation of Three Authorizations of Emergency Use of In Vitro Diagnostic Devices for Detection and/or Diagnosis of COVID–19; Availability,Notice,Announcement,2025-03-20T04:00:00Z,2025,3,,,2025-03-20T18:40:40Z,2025-04710,0,0,0900006486a12c61